SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cristiano Matos, Florence van Hunsel, João Joaquim, Are consumers ready to take part in the Pharmacovigilance System?—a Portuguese preliminary study concerning ADR reporting, European Journal of Clinical Pharmacology, 2015, 71, 7, 883

    CrossRef

  2. 2
    C. Petersen, P. DeMuro, Legal and Regulatory Considerations Associated with Use of Patient-Generated Health Data from Social Media and Mobile Health (mHealth) Devices, Applied Clinical Informatics, 2015, 6, 1, 16

    CrossRef

  3. 3
    Jarernsiripornkul Narumol, Patsuree Arunrot, Janet Krska, Survey of patients’ experiences and their certainty of suspected adverse drug reactions, International Journal of Clinical Pharmacy, 2015, 37, 1, 168

    CrossRef

  4. 4
    Rosalind L Smyth, Matthew Peak, Mark A Turner, Anthony J Nunn, Paula R Williamson, Bridget Young, Janine Arnott, Jennifer R Bellis, Kim A Bird, Louise E Bracken, Elizabeth J Conroy, Lynne Cresswell, Jennifer C Duncan, Ruairi M Gallagher, Elizabeth Gargon, Hannah Hesselgreaves, Jamie J Kirkham, Helena Mannix, Rebecca MD Smyth, Signe Thiesen, Munir Pirmohamed, ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods, Programme Grants for Applied Research, 2014, 2, 3, 1

    CrossRef

  5. 5
    Florence Margraff, Delphine Bertram, Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries, Drug Safety, 2014, 37, 6, 409

    CrossRef

  6. 6
    Pedro Inácio, Marja Airaksinen, Afonso Cavaco, Language does not come “in boxes”: Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese, Research in Social and Administrative Pharmacy, 2014,

    CrossRef

  7. 7
    Paolo Baldo, Paolo De Paoli, Pharmacovigilance in oncology: evaluation of current practice and future perspectives, Journal of Evaluation in Clinical Practice, 2014, 20, 5
  8. 8
    James H. Lewis, Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist, Pharmaceutical Medicine, 2013, 27, 3, 165

    CrossRef

  9. 9
    Adriana Parrella, Annette Braunack-Mayer, Michael Gold, Helen Marshall, Peter Baghurst, Healthcare providers’ knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study, BMC Health Services Research, 2013, 13, 1, 313

    CrossRef

  10. 10
    Janet Krska, Charles W. Morecroft, Helen Poole, Philip H. Rowe, Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study, International Journal of Clinical Pharmacy, 2013, 35, 6, 1161

    CrossRef

  11. 11
    Linda Härmark, Miguel Lie-Kwie, Lisette Berm, Han Gier, Kees Grootheest, Patients’ motives for participating in active post-marketing surveillance, Pharmacoepidemiology and Drug Safety, 2013, 22, 1
  12. 12
    Janet Krska, Charles W. Morecroft, Patients’ Use of Information about Medicine Side Effects in Relation to Experiences of Suspected Adverse Drug Reactions: A Cross-Sectional Survey in Medical In-Patients, Drug Safety, 2013, 36, 8, 673

    CrossRef

  13. 13
    Ethan Basch, Systematic Collection of Patient-Reported Adverse Drug Reactions: A Path to Patient-Centred Pharmacovigilance, Drug Safety, 2013, 36, 4, 277

    CrossRef

  14. 14
    Janet Krska, Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs), Pharmacoepidemiology and Drug Safety, 2013, 22, 10
  15. 15
    Janine Arnott, Hannah Hesselgreaves, Anthony J. Nunn, Matthew Peak, Munir Pirmohamed, Rosalind L. Smyth, Mark A. Turner, Bridget Young, What can we learn from parents about enhancing participation in pharmacovigilance?, British Journal of Clinical Pharmacology, 2013, 75, 4
  16. 16
    Andreas Vilhelmsson, Tommy Svensson, Anna Meeuwisse, Anders Carlsten, Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association, BMC Pharmacology and Toxicology, 2012, 13, 1, 19

    CrossRef

  17. 17
    Narumol Jarernsiripornkul, Piyanida Senacom, Verawan Uchaipichat, Nataporn Chaipichit, Janet Krska, Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy, Epilepsy & Behavior, 2012, 24, 1, 102

    CrossRef

  18. 18
    Abdalla Omer Elkhawad, Pharmacoinformatics and Drug Discovery Technologies, 2012,

    CrossRef